ARTICLE | Clinical News
Immunomedics regulatory update
April 15, 1996 7:00 AM UTC
The FDA issued an approvable letter for IMMU's CEA-Scan, its in vivo diagnostic imaging product for colorectal cancer. ...
The FDA issued an approvable letter for IMMU's CEA-Scan, its in vivo diagnostic imaging product for colorectal cancer. ...